Annalise.ai’s technology- ‘Annalise Enterprise CXR,’ is a decision support solution to assist the large volume of TB screening cases Lumus Imaging reports daily. The Annalise Enterprise system promises to enhance the early detection and management of TB as it is specifically tailored to support the analysis of chest X-rays.
Lumus Imaging Group Executive, Dr. Phil Lucas said he is thrilled to be utilising the focused capabilities of this cutting-edge machine.
“This technology will certainly enhance diagnostic accuracy, efficiency, ultimately revolutionising patient care,” he said.
Additionally, Lumus Imaging will use this advanced AI technology to augment its Radiologists’ capacity through:
Accurate Imaging Analysis: AI-powered algorithms applied to analyse chest X-rays with high precision.
Insightful Decision Support: Detailed insights to support patient management strategies and treatment planning.
User-friendly Interface – Intuitive design and user-friendly interface ensuring quick adoption and minimal training.
Lumus Imaging Radiologist, Dr Mark Benson said the Annalise AI system is performing well and has provided robust assistance in his TB screening reporting.
“I am also pleased with the clinical support provided by the Annalise Ai team post-implementation to optimise the sensitivity and specificity of the solution,” said Benson.
Co-founder and deputy CEO of Annalise.ai, Dimitry Tran said: “We are proud to support Lumus Imaging in TB screening and in turn contribute to public health. By identifying scans with a high likelihood of TB using AI, we enable Radiologists to prioritise these cases, thus optimising their workflow and enhancing efficiency.” |
